With rapid lifestyle transitions, the increasing burden of nonalcoholic fatty liver disease
(NAFLD) in China has emerged as a major public health issue. To obtain a comprehensive …

Liver diseases affect millions of people worldwide. In most developed countries, the
incidence of viral hepatitis is waning as a result of modern advances in disease prevention …

The overproduction of reactive oxygen species (ROS) and consequent oxidative stress
contribute to the pathogenesis of acute and chronic liver diseases. It is now acknowledged …

Colorectal cancer (CRC) is one of the most commonly diagnosed cancers, and it is
characterized by genetic and epigenetic alterations, as well as by inflammatory cell …

Non-alcoholic fatty liver disease (NAFLD) is a major chronic liver disease that can lead to
liver cirrhosis, liver cancer, and ultimately death. NAFLD is pathologically classified as non …

Background: The worldwide outbreak of COVID-19 infected millions of people. Some
patients had gastrointestinal (GI) symptoms, abnormal liver function, digestive system …

The article reports that non-alcoholic fatty liver disease (NAFLD) is an acquired metabolic
stress-induced liver disease associated closely with genetic susceptibility and insulin …

Body mass index (BMI) is associated with fatty liver risk, however, the dose-response
relationship between continuous BMI changes and fatty liver risk has not been clearly …

The prevalence of nonalcoholic fatty liver disease (NAFLD) has been increasing over the
years and is now as high in Asia as in the Western world, so much so that it should no longer …

As in the West, nonalcoholic fatty liver disease (NAFLD) is the commonest chronic liver
disease in Asia, with a prevalence higher than 40% in some countries. The risk factors for …